How's this for transparency? "AstraZeneca declined to comment, as did an FDA spokeswoman." But at least the vaccine trials get the green light to proceed in the US after many weeks of review. by
. didn't find that the Covid-19 vaccine from and was responsible for the two suspicious safety cases that triggered the testing pause, but couldn't rule out a link either, reports
Very good news. Robust independent oversight of clinical trials is essential for all our confidence in vaccines and treatments via
Covid-19 vaccine trial From AstraZeneca PLC and the University of Oxford can resume in U.S., according to a person familiar with the matter via